CUE 8-K: SEC filing

Cue Biopharma

Filed with the SEC on · accession 0001193125-26-463741

CUE filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -12.5% by the first close after the filing.

Summary of the filing

Cue Biopharma issued a press release announcing financial results for the quarter ended September 30, 2026, along with recent business highlights, and reported a change in its principal executive office address to Somerville, Massachusetts.

Key details

RegistrantCue Biopharma, Inc.
President and chief executive officerShao-Lee Lin

How CUE stock reacted

Close before

$16.12

Nov 13, 2026

First close after

-12.53%

$14.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CUE?

Click here

Frequently asked questions

What did CUE file with the SEC on Nov 16, 2026?

CUE filed a 8-K (SEC filing). Cue Biopharma issued a press release announcing financial results for the quarter ended September 30, 2026, along with recent business highlights, and reported a change in its principal executive office address to Somerville, Massachusetts.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CUE stock react to this filing?

CUE closed at $16.12 before the filing and $14.10 on Nov 16, 2026 (-12.53%).

Other CUE SEC filings

Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days